Related references
Note: Only part of the references are listed.ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer
M. van Geldermalsen et al.
ONCOGENE (2016)
Glutamine and alanyl-glutamine promote crypt expansion and mTOR signaling in murine enteroids
Sean R. Moore et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2015)
Lactate dehydrogenase 5: An old friend and a new hope in the war on cancer
Katarzyna Augoff et al.
CANCER LETTERS (2015)
FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function
In-Sung Song et al.
GASTROENTEROLOGY (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Inhibition of lactate dehydrogenase activity as an approach to cancer therapy
Luigi Fiume et al.
FUTURE MEDICINAL CHEMISTRY (2014)
CpG Island Methylator Phenotype Is Associated With Response to Adjuvant Irinotecan-Based Therapy for Stage III Colon Cancer
Stacey Shiovitz et al.
GASTROENTEROLOGY (2014)
Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
Kivanc Birsoy et al.
NATURE (2014)
Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
Fotios Loupakis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Metformin: A Potential Therapeutic Agent for Recurrent Colon Cancer
Pratima Nangia-Makker et al.
PLOS ONE (2014)
Chemopreventive drugs: Mechanisms via inhibition of cancer stem cells in colorectal cancer
Tae Il Kim
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells
Yue-Zhi Lee et al.
ONCOTARGET (2014)
Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism
Sarah-Maria Fendt et al.
CANCER RESEARCH (2013)
Tumour heterogeneity and cancer cell plasticity
Corbin E. Meacham et al.
NATURE (2013)
Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth
Heather A. Hirsch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects
Arian Emami Riedmaier et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue Type
Mariia O. Yuneva et al.
CELL METABOLISM (2012)
Metformin use is associated with a decreased incidence of colorectal adenomas in diabetic patients with previous colorectal cancer
Jin Ha Lee et al.
DIGESTIVE AND LIVER DISEASE (2012)
Addition of cetuximab to chemotherapy as first-line treatment for KRAS wild-type metastatic colorectal cancer: Pooled analysis of the CRYSTAL and OPUS randomised clinical trials
Carsten Bokemeyer et al.
EUROPEAN JOURNAL OF CANCER (2012)
Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma
Shi L. Sheng et al.
FEBS JOURNAL (2012)
The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus
Jin Ha Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review)
Jie Zheng
ONCOLOGY LETTERS (2012)
Glutamine fuels a vicious cycle of autophagy in the tumor stroma and oxidative mitochondrial metabolism in epithelial cancer cells Implications for preventing chemotherapy resistance
Ying-Hui Ko et al.
CANCER BIOLOGY & THERAPY (2011)
Metformin Decreases the Dose of Chemotherapy for Prolonging Tumor Remission in Mouse Xenografts Involving Multiple Cancer Cell Types
Dimitrios Iliopoulos et al.
CANCER RESEARCH (2011)
Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes A meta-analysis
Zhi-Jiang Zhang et al.
DIABETES CARE (2011)
Annual Report to the Nation on the Status of Cancer, 1975-2006, Featuring Colorectal Cancer Trends and Impact of Interventions (Risk Factors, Screening, and Treatment) to Reduce Future Rates
Brenda K. Edwards et al.
CANCER (2010)
Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase
Carolyn Algire et al.
ENDOCRINE-RELATED CANCER (2010)
Empowering self-renewal and differentiation: the role of mitochondria in stem cells
Jalees Rehman
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
Metformin Suppresses Azoxymethane-Induced Colorectal Aberrant Crypt Foci by Activating AMP-Activated Protein Kinase
Kunihiro Hosono et al.
MOLECULAR CARCINOGENESIS (2010)
Glioblastoma Cells Require Glutamate Dehydrogenase to Survive Impairments of Glucose Metabolism or Akt Signaling
Chendong Yang et al.
CANCER RESEARCH (2009)
Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
Heather A. Hirsch et al.
CANCER RESEARCH (2009)
The axis of mTOR-mitochondria-ROS and stemness of the hematopoietic stem cells
Chong Chen et al.
CELL CYCLE (2009)
Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells
Mariia Yuneva et al.
JOURNAL OF CELL BIOLOGY (2007)
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin
RJ Shaw et al.
SCIENCE (2005)
Glucose metabolism heterogeneity in human and mouse malignant glioma cell lines
CE Griguer et al.
JOURNAL OF NEURO-ONCOLOGY (2005)
Systematic review of microsatellite instability and colorectal cancer prognosis
S Popat et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)